IOVA
Iovance Biotherapeutics Inc
NASDAQ: IOVA · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$1.41B
P/E ratio
—
P/S ratio
5.36x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$2 – $6
Volume
17.4M
Iovance Biotherapeutics Inc (IOVA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $238000.00 | $1.19M | $164.07M | $263.50M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +399.6% | +13699.0% | +60.6% |
| Cost of revenue | — | $1332.00 | — | $19.30M | $0.00 | $4.66M | $88221.00 | $999000.00 | $978000.00 | $952000.00 | $956000.00 | $8.12M | $8.71M | $13.98M | $21.14M | $10.76M | $124.00M | $7.29M |
| Gross profit | — | — | — | $-19.30M | $0.00 | $-4.66M | $-9.34M | $-999000.00 | $-978000.00 | $-952000.00 | $-956000.00 | $-8.12M | $-8.71M | $-13.98M | $-21.14M | $-9.57M | $40.08M | $256.22M |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -8880.3% | -804.5% | 24.4% | 97.2% |
| R&D | — | — | — | $1.76M | $1.66M | $1.33M | $2.71M | $15.47M | $28.04M | $71.61M | $99.83M | $166.02M | $201.73M | $259.04M | $294.78M | $344.08M | $282.34M | $300.27M |
| SG&A | $25558.00 | $14440.00 | $756000.00 | $19.30M | $6.48M | $4.66M | $9.34M | $12.39M | $25.60M | $21.26M | $28.43M | $40.85M | $60.21M | $83.66M | $104.10M | $27.70M | $51.80M | $152.32M |
| Operating income | $-57140.00 | $-15772.00 | $-815000.00 | $-21.22M | $-8.13M | $-22.64M | $-12.04M | $-27.86M | $-53.64M | $-92.88M | $-128.26M | $-206.87M | $-261.94M | $-342.70M | $-398.88M | $-460.56M | $-395.28M | $-403.36M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -167595.8% | -38735.0% | -240.9% | -153.1% |
| EBITDA | $-55808.00 | $-14440.00 | $-1.55M | $-20.54M | $-8.13M | $-24.93M | $-11.95M | $-26.86M | $-52.66M | $-91.92M | $-127.30M | $-205.70M | $-260.80M | $-328.72M | $-377.74M | $-427.43M | $-351.67M | $-357.11M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -158715.5% | -35948.9% | -214.3% | -135.5% |
| EBIT | $-57140.00 | $-15772.00 | $-1.61M | $-20.54M | $-8.13M | $-24.94M | $-12.03M | $-27.86M | $-53.64M | $-92.88M | $-128.26M | $-206.87M | $-261.94M | $-342.70M | $-398.88M | $-460.56M | $-395.28M | $-393.05M |
| Interest expense | $0.00 | $0.00 | $0.00 | $151507.00 | $0.00 | $444729.00 | $5660.00 | $200000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.36M | $451000.00 | $2.98M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-57140.00 | $-15772.00 | $-1.61M | $-25.69M | $-3.31M | $-25.38M | $-12.04M | $-27.66M | $-52.89M | $-92.06M | $-123.58M | $-187.07M | $-259.58M | $-327.82M | $-389.92M | $-444.04M | $-372.18M | $-390.98M |
| Net income growth (YoY) | — | +72.4% | -10095.3% | -1497.9% | +87.1% | -667.3% | +52.6% | -129.8% | -91.2% | -74.1% | -34.2% | -51.4% | -38.8% | -26.3% | -18.9% | -13.9% | +16.2% | -5.1% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -163833.2% | -37345.4% | -226.8% | -148.4% |